Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 13, 2017

View Archived Issues

AVEO Oncology reports clinical, regulatory progress with tivozanib

Cellceutix initiates main clinical site for phase IIa trial of Kevetrin

Hybrigenics presents preliminary results of phase II trial of inecalcitol in patients with CML

Phase I/II results for VM-202 in subjects with amyotrophic lateral sclerosis

Seattle Genetics and Immunomedics enter global license agreement for sacituzumab govitecan

Two-year data for trans-sodium crocetinate plus temozolomide and RT in glioblastoma multiforme

Merck Sharp & Dohme begins phase I testing of MK-1454 in advanced solid tumors, lymphomas

New autism research center established at MIT

Reckitt Benckiser to acquire Mead Johnson Nutrition

Alexo initiates phase I testing of ALX-148

Hutchison MediPharma initiates first-in-human study of HMPL-453

Cancer Research UK announces the first recipients of its global Grand Challenge competition

MMJ PhytoTech announces phase II study of PTL-101 to treat refractory epilepsy in children

TP53 gene mutations linked to lower survival after stem cell transplant for myelodysplastic syndrome

Novartis files for Japanese approval of Tasigna in pediatric CML

Acacia reports results from final pivotal trial of Baremsis for rescue treatment of PONV

STADA Arzneimittel confirms expressions of interest in company

Furaprevir phase II study completed successfully in Taiwan

GlaxoSmithKline reflects on highlights of fourth quarter 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...